FDA Approves Genentech Drug as a Weapon for Fighting Breast Cancer
Posted in Pharmaceutical Biotechnology on Feb 23rd, 2008
(NewsVisual, powered by IntellectSpace) — The San Francisco-based biotechnology company Genentech Inc (NYSE: DNA) announced on Friday that the U.S. Food and Drug Administration (FDA) granted accelerated approval for one of its drugs to be used metastatic breast cancer. The FDA’s approval means that the company’s drug Avastin can be used in combination along [...]